Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium for Oral Suspension USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent drug; Clavulanate Potassium component
- Products
-
- Amoxicillin and Clavulanate Potassium for Oral Suspension USP
- Where it was sold
-
Distributed in three (3) States: MS, OH, CA.
States: California, Mississippi, Ohio
- Units affected
- 4680 cartons
- About this recall
- Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.